← Back to Patent Explorer
US4260627A Expired / Lapsed US ⏱️ 0.0 years remaining

1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids

Assignee: Merck and Co Inc
•
Filing: 1978-10-24
•
Granted: 1981-04-07
•
Expires: 1998-10-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids of the following structure: <IMAGE> wherein R1, R2, R3 and R4 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, aryl, and aralkyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Burton G. Christensen
  • 👤 David H. Shih

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 06:15
CPC Classifications
C; C07; C07D; C07D205/00; C07D205/02; C07D205/06; C07D205/08; A; A61; A61P; A61P31/00; A61P31/04; C07C; C07C205/00; C07C205/39; C07C205/42; C07C45/00; C07C45/61; C07C45/67; C07C45/68; C07C45/72; C07C45/74; C07D477/00; C07D477/10; C07D477/12; C07D477/14; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/18; C07F7/1804; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/568

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 142 words
A compound having the structure: ##STR184## and the pharmaceutically acceptable salts thereof; wherein R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of hydrogen (R 3 is not hydrogen), and substituted and unsubstituted: alkyl having 1-6 carbon atoms, alkenyl and alkynyl having 2-6 carbon atoms, aryl and aralkyl having 6-10 ring carbon atoms and 1-6 carbon atoms in the alkyl chain, cycloalkyl and cycloalkylalkyl having 3 to 6 ring carbon atoms and 1-6 carbon atoms in the alkyl moiety; wherein the substituents on R 1 , R 2 , R 3 and R 4 are selected from chloro, bromo, fluoro, hydroxyl, amino, mono-, di- and trialkyl substituted amino (each alkyl having 1-6 carbon atoms) alkoxyl having 1-6 carbon atoms, guanidino, cyano, amidino and carboxyl; with the proviso that R 4 is not hydrogen.
Claim 2
Dependent Claim 142 words
A compound having the structure: ##STR184## and the pharmaceutically acceptable salts thereof; wherein R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of hydrogen (R 3 is not hydrogen), and substituted and unsubstituted: alkyl having 1-6 carbon atoms, alkenyl and alkynyl having 2-6 carbon atoms, aryl and aralkyl having 6-10 ring carbon atoms and 1-6 carbon atoms in the alkyl chain, cycloalkyl and cycloalkylalkyl having 3 to 6 ring carbon atoms and 1-6 carbon atoms in the alkyl moiety; wherein the substituents on R 1 , R 2 , R 3 and R 4 are selected from chloro, bromo, fluoro, hydroxyl, amino, mono-, di- and trialkyl substituted amino (each alkyl having 1-6 carbon atoms) alkoxyl having 1-6 carbon atoms, guanidino, cyano, amidino and carboxyl; with the proviso that R 4 is not hydrogen.
Claim 3
Dependent Claim 40 words
A compound having the structure: ##STR185## and the pharmaceutically acceptable salts thereof; wherein R 3 and R 4 are alkyl, cyclopropyl, benzyl or phenyl; R 1 is hydrogen and R 2 is alkyl or phenylalkyl substituted by hydroxyl or amino.
Claim 4
Dependent Claim 40 words
A compound having the structure: ##STR185## and the pharmaceutically acceptable salts thereof; wherein R 3 and R 4 are alkyl, cyclopropyl, benzyl or phenyl; R 1 is hydrogen and R 2 is alkyl or phenylalkyl substituted by hydroxyl or amino.
Claim 5
Dependent Claim 27 words
A compound according to claim 2 wherein R 3 and R 4 are methyl, ethyl, isopropyl, t-butyl or phenyl and R 2 is 1-hydroxyethyl, methyl, or hydroxymethyl.
Claim 6
Dependent Claim 138 words
A compound having the structure: ##STR186## and the pharmaceutically acceptable salts thereof: wherein R 4 is selected from the group consisting of: ##STR187## and wherein R 1 , R 2 and R 3 are independently selected from the group consisting of hydrogen (R 3 is not hydrogen), and substituted and unsubstituted: alkyl having 1-6 carbon atoms, alkenyl and alkynyl having 2-6 carbon atoms, aryl and aralkyl having 6-10 ring carbon atoms and 1-6 carbon atoms in the alkyl chain, cycloalkyl and cycloalkylalkyl having 3-6 ring carbon atoms and 1-6 carbon atoms in the alkyl moiety; wherein the substituents on R 1 , R 2 , and R 3 are selected from chloro, bromo, fluoro, hydroxyl, amino, mono-, di- and trialkyl substituted amino (each alkyl having 1-6 carbon atoms) alkoxyl having 1-6 carbon atoms, guanidino, cyano, amidino, and carboxyl.
Claim 7
Dependent Claim 138 words
A compound having the structure: ##STR186## and the pharmaceutically acceptable salts thereof: wherein R 4 is selected from the group consisting of: ##STR187## and wherein R 1 , R 2 and R 3 are independently selected from the group consisting of hydrogen (R 3 is not hydrogen), and substituted and unsubstituted: alkyl having 1-6 carbon atoms, alkenyl and alkynyl having 2-6 carbon atoms, aryl and aralkyl having 6-10 ring carbon atoms and 1-6 carbon atoms in the alkyl chain, cycloalkyl and cycloalkylalkyl having 3-6 ring carbon atoms and 1-6 carbon atoms in the alkyl moiety; wherein the substituents on R 1 , R 2 , and R 3 are selected from chloro, bromo, fluoro, hydroxyl, amino, mono-, di- and trialkyl substituted amino (each alkyl having 1-6 carbon atoms) alkoxyl having 1-6 carbon atoms, guanidino, cyano, amidino, and carboxyl.
Claim 8
Dependent Claim 17 words
A compound according to claim 4 wherein R 3 is alkyl having 1-6 carbon atoms or phenyl.
Claim 9
Dependent Claim 26 words
An antibiotic pharmaceutical composition comprising a therapeutically effective amount of a compound according to claims 1, 2, 3, 4 or 5 and a pharmaceutical carrier therefor.

References Cited (Backward Citations)

US3950357A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-04-06 1984-10-06 1985-04-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-04-06 1988-10-06 1989-04-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-04-06 1992-10-06 1993-04-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag